471820 — Cellromax Science Co Share Price
Last trade - 00:00- KR₩58bn
- KR₩37bn
- KR₩22bn
- 75
- 58
- 24
- 54
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.31 | ||
| Price to Tang. Book | 1.42 | ||
| Price to Free Cashflow | 16.42 | ||
| Price to Sales | 2.69 | ||
| EV to EBITDA | 6.21 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.98% | ||
| Return on Equity | 10.23% | ||
| Operating Margin | 25.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | n/a | 18,837.36 | 21,085.86 | 19,309.52 | 21,630.34 | n/a | n/a | 4.72% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +18.76 | -4.08 | -6.13 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cellromax Science Co Ltd is a Korea-based company primarily engaged in the development and distribution of health food products. The Company primarily engages in the development and distribution of health functional foods, functional cosmetics, and general medicines. In addition, the Company’s brands include ‘Cellromax’ and so on.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 22nd, 2014
- Public Since
- December 13th, 2024
- No. of Shareholders
- 4,780
- No. of Employees
- 53
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 11,355,752
- Address
- 357 Guseong-Ro, Giheung-Gu, YONGIN, 16914
- Web
- https://www.cellromax.kr
- Phone
- +82 316621395
- Auditors
- Samil Accounting Corp.
Similar to 471820
Ameridge
Korea Exchange - KOSDAQ
Chungdamglobal Co
Korea Exchange - KOSDAQ
DEUTSCH MOTORS
Korea Exchange - KOSDAQ
DYD Co
Korea Exchange - KOSDAQ
Flask Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:50 UTC, shares in Cellromax Science Co are trading at KR₩5,120. This share price information is delayed by 15 minutes.
Shares in Cellromax Science Co last closed at KR₩5,120 and the price had moved by over the past 365 days. In terms of relative price strength the Cellromax Science Co share price has matched the FTSE Developed Asia Pacific Index by over the past year.
There is no consensus recommendation for this security.
Find out moreThe Cellromax Science Co dividend yield is 3.22% based on the trailing twelve month period.
Last year, Cellromax Science Co paid a total dividend of KR₩165, and it currently has a trailing dividend yield of 3.22%. We do not have any data on when Cellromax Science Co is to next pay dividends.
We do not have data on when Cellromax Science Co is to next pay dividends. The historic dividend yield on Cellromax Science Co shares is currently 3.22%.
To buy shares in Cellromax Science Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩5,120, shares in Cellromax Science Co had a market capitalisation of KR₩58bn.
Here are the trading details for Cellromax Science Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 471820
Based on an overall assessment of its quality, value and momentum Cellromax Science Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cellromax Science Co. Over the past six months, its share price has matched the FTSE Developed Asia Pacific Index by .
As of the last closing price of KR₩5,120, shares in Cellromax Science Co were trading -1.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cellromax Science Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩5,120.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Cellromax Science Co's directors